Navigation Links
Collagen Meniscus Implant

ProductsCollagen Meniscus Implant
Company ReGen Biologics
Item Collagen Meniscus Implant
Features 
  • A type I collagen implant designed for patients with an irreparable meniscus tear or loss of meniscus tissue
  • The purpose of the CMI is to assist patients to regain mobility and return to a more vigorous lifestyle, while forestalling or minimizing degenerative joint disease.
  • Assists the body to generate new tissue, which replaces the damaged meniscus tissue removed by the surgeon.
  • The result is designed to provide patients with increased mobility and a return to a more active lifestyle.
  • Description The Collagen Meniscus Implant (CMI) is a type I collagen implant designed for patients with an irreparable meniscus tear or loss of meniscus tissue, typically through an arthroscopic partial meniscectomy procedure. The purpose of the CMI is to assist patients to regain mobility and return to a more vigorous lifestyle, while forestalling or minimizing degenerative joint disease. The Collagen Meniscus Implant is a method of regenerating meniscus tissue using the body's own healing process. A next generation approach to tissue repair, the CMI assists the body to generate new tissue, which replaces the damaged meniscus tissue removed by the surgeon. The result is designed to provide patients with increased mobility and a return to a more active lifestyle. The CMI is a resorbable type I collagen scaffold designed to minimize progressive degenerative changes in the knee after a partial meniscectomy by providing an alternative to the permanent loss of meniscus tissue. The CMI is similar to the natural shape of the meniscus and it is made of highly purified collagen, the most commonly found protein in the body. In cases where meniscus tissue cannot be repaired by suturing, the damaged tissue is removed and the CMI is sutured in place filling the defect where tissue is missing. Once sutured in place, the CMI provides a matrix into which the body's own cells may begin to move or migrate. New meniscus tissue is formed as these cells migrate and multiply. As this tissue regeneration takes place, the CMI is absorbed by the body. The regenerated tissue has the potential to restore function, reduce pain, and possibily suspend the degenerative process that begins with the loss of meniscus tissue. The CMI is made of type I collagen and it is a biocompatible, bioresorbable material that is designed to provide a scaffold for tissue growth when implanted in the knee. The surgeon sutures the CMI into the area where the meniscus tissue is missing. Once implanted, the CMI's highly porous matrix allows cellular ingrowth from the patient's own cells. This process regenerates meniscus tissue which provides the potential for restoring function, reducing pain and possibly arresting the degenerative process that begins with the loss of meniscus tissue.
    Info ReGen Biologics
    Customer Service: (201) 651-5140
    Web site: http://www.regenbio.com

    Related medicine products :

    1. Temporary Collagen Plugs
    2. Ultrafoam Collagen Sponge
    3. UltraPlug Collagen Absorbably Punctal Plugs
    4. INSTAT Collagen Absorbable Hemostat
    5. Pelvicol Acellular Collagen Matrix (Continence)
    6. Contigen Bard Collagen Implant
    7. Pelvicol® Acellular Collagen Matrix
    8. PelviSoft® Acellular Collagen BioMesh
    9. Hydrix XM Collagen Matrix
    10. Zyderm® and Zyplast® Injectable Collagen Implants
    11. CosmoDerm®and CosmoPlast® Collagen Replacement Therapy®
    15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle. Designated most popular model or size....
    Grooved roller, on which knife oscillates....
    ... blade. 17 mm wide blade. ... inches. Note: Has Marcks attachment ... to any thickness up to ... thicker grafts or split graft. ...
    5 mm small, sharp, protected blade. Angled at 105 degrees. Flat handle. Designated most popular model or size....
    Medicine Products:
    (Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... of ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and ... may have been used to remove decayed dental matter, and that teeth were then ...
    (Date:4/21/2017)... ... 21, 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD ... a benign bony lump located on the forehead usually attributed to a facial fracture. ... and pain. Dr. Shah has discovered an approach that is minimally invasive. He is ...
    (Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
    (Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility ... Hong Kong to support teaching, learning and research. It is also the largest research ... Hong Kong. , With an area of 620 square metres and more than ...
    (Date:4/21/2017)... ... April 21, 2017 , ... Airway Management, the medical device ... highly regarded and well renowned Asian distributor, Discovery Sleep. The agreement ... Pillow Mask, and will stabilize and strengthen Airway’s presence with a dedicated, reputable ...
    Breaking Medicine News(10 mins):
    (Date:4/20/2017)... Research and Markets has announced the addition of ... Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ... ... at US$ 7,167.6 Mn in 2015, and is expected to ... of 5.6% from 2016 to 2024. The ...
    (Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
    (Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
    Breaking Medicine Technology: